SV Health Investors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-994,079
Closed -$17.9M 5
2022
Q2
$17.9M Sell
994,079
-296,899
-23% -$4.82M 40.94% 1
2022
Q1
$20.7M Sell
1,290,978
-650,140
-33% -$11.7M 24.99% 3
2021
Q4
$47.5M Hold
1,941,118
30.69% 2
2021
Q3
$45.2M Sell
1,941,118
-970,559
-33% -$23.5M 22.12% 2
2021
Q2
$79.8M Hold
2,911,677
34.77% 1
2021
Q1
$107M Buy
+2,911,677
New +$103M 40.09% 1

Other funds holding AHCO

SV Health Investors's AHCO Position: Q3 2022 in Review

SV Health Investors sold out of AdaptHealth (AHCO) in Q3 2022, closing a stake of 994,079 shares — an estimated $17.9M sold.

SV Health Investors first reported a position in AHCO in Q1 2021 and held it in 6 quarters. The position peaked at $107M in Q1 2021. 183 funds tracked by Wall St. Rank hold AHCO as of Q3 2022.

  • SV Health Investors reported no remaining AdaptHealth position as of Q3 2022 after selling out during the quarter.
  • SV Health Investors sold 994,079 AdaptHealth shares in Q3 2022, an estimated $17.9M.
  • SV Health Investors first reported a position in AdaptHealth in Q1 2021 and held it in 6 quarters.
  • SV Health Investors's AdaptHealth position peaked at $107M in Q1 2021.
  • 183 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2022.

Based on SV Health Investors's 13F filing for Q3 2022, filed 7 Nov 2022.